No-Cost, No-Obligation Ethicon Physiomesh Attorney Case Review

Ethicon Physiomesh Attorney
Ethicon Physiomesh Lawsuit News

Physiomesh Problems Are Certain To Occur For Many Years To Come

Even though Johnson & Johnson pulled Physiomesh from the market that action could have come too late for thousands of patients

Tuesday, October 30, 2018 - In spite of the fact that Ethicon voluntarily and permanently withdrew Physiomesh from the worldwide market, thousands of men and women are forced to live with the defective medical device inside of them. It may be just a matter of time before Physiomesh fails and more and more people must undergo dangerous revision surgery to locate and remove pieces of the device and repair a hernia. It is widely accepted that Physiomesh fails because it is made of Polypropylene, a synthetic plastic that is incompatible with organic human tissues, according to the National Institute of Health. Johnson & Johnson (JNJ), the parent company of Ethicon, maker of Physiomesh, was so pessimistic about the product's ability to deliver on the company's promise of providing a better way to repair and support hernias that the company was willing to forgo millions of dollars of profits and voluntarily remove the product from the market. It looks as if JNJ might have been trying to avoid a repeat of the millions of dollar the company was forced to pay to women that were injured by the transvaginal mesh, a very similar medical device. It is possible that thousands of individuals in the near future will be consulting with Physiomesh malpractice attorneys to see if they qualify to receive monetary compensation from Johnson & Johnson for rushing a faulty medical device to market.

Physiomesh is a flexible, composite mesh that designed to support the abdominal wall after laparoscopic hernia repair surgery.

Physiomesh is made of synthetic polypropylene encased in partially absorbable fibers. The recovery time from Physiomesh hernia repair surgery can be four to six week but many patients developed severe pain when Physiomesh degraded and pulled free from the spot atop a hernia it was intended to support. As a result, lawsuits were filed against Johnson & Johnson and the company decided to pull the medical device from the market to cut their losses as short as possible. At the core of the problem is the fact that Physiomesh polypropylene degrades, crumples, buckles and can migrate to other parts of the abdominal cavity potentially causing dangerous blockages in the small intestines. Physiomesh patients report difficulty in urinating, extremely sharp, stabbing pain, infections, and redness. Nausea, vomiting and high fever can also occur from the body's rejection of Physiomesh.

Doctors using Physiomesh or any approved medical device believe that if the device was safe enough to pass the approval of the Food and Drug Administration (FDA), that it has been thoroughly tested. New information has revealed, unfortunately, that this is simply not the case. The Netflix documentary film "The Bleeding Edge" exposed the faulty logic behind the FDA's 501 (k) fast-track medical device approval program, and Ethicon may have taken advantage of the fast-track loophole. Physiomesh was never required to pass pre-market human testing nor the scrutiny of a panel of FDA scientists because it was considered by the FDA to be "substantially similar" to other mesh hernia repair devices already on the market and was granted immediate approval. The devices that Physiomesh occurred compared with could have been flawed devices themselves. Physiomesh problems continue to be reported to doctors by patients suffering from Physiomesh side effects.

More Recent Ethicon Physiomesh Lawsuit News:

Lawyers for Ethicon Physiomesh Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. OnderLaw has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. OnderLaw has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.